Andrew M Fribley
Overview
Explore the profile of Andrew M Fribley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
329
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yancey C, Hart L, Lad A, Birbeck J, Song S, Mohamed O, et al.
Environ Sci Technol
. 2024 Nov;
58(45):19936-19947.
PMID: 39529579
spp. threaten freshwater ecosystems through the proliferation of cyanobacterial harmful algal blooms (cyanoHABs) and production of the hepatotoxin, microcystin. While microcystin and its biosynthesis pathway, encoded by the genes, have...
2.
Gauss C, Stone L, Ghafouri M, Quan D, Johnson J, Fribley A, et al.
Cells
. 2024 Jun;
13(12.
PMID: 38920648
Although there have been some advances during in recent decades, the treatment of head and neck squamous cell carcinoma (HNSCC) remains challenging. Resistance is a major issue for various treatments...
3.
Purandare N, Gomez-Lopez N, Arenas-Hernandez M, Galaz J, Romero R, Xi Y, et al.
Placenta
. 2023 Aug;
140:66-71.
PMID: 37544161
Intra-amniotic inflammation leading to preterm birth is one of the leading causes of neonatal morbidity and mortality. We recently reported that the mitochondrial levels of MNRR1 (Mitochondrial Nuclear Retrograde, Regulator...
4.
Ghafouri M, Gauss C, Fribley A
Methods Mol Biol
. 2022 Jan;
2378:317-327.
PMID: 34985709
The identification of small molecules and natural product extracts that enhance or interfere with the productivity of protein folding in the endoplasmic reticulum (ER) has the potential to improve a...
5.
Cole D, Svider P, Shenouda K, Lee P, Yoo N, McLeod T, et al.
Exp Cell Res
. 2019 May;
382(1):111386.
PMID: 31075256
Many FDA-approved anti-cancer therapies, targeted toward a wide array of molecular targets and signaling networks, have been demonstrated to activate the unfolded protein response (UPR). Despite a critical role for...
6.
Shah OBrien P, Xi Y, Miller J, Brownell A, Zeng Q, Yoo G, et al.
J Clin Med
. 2019 May;
8(5).
PMID: 31064122
A paucity of advances in the development of novel therapeutic agents for squamous cell carcinomas of the head and neck, oral cavity (OSCC) and oropharynx, has stagnated disease free survival...
7.
Ramsey T, Hojjat H, Yuhan B, Svider P, Eloy J, Folbe A, et al.
Laryngoscope
. 2019 Mar;
129(11):2482-2486.
PMID: 30889288
Objectives: Nasopharyngeal carcinoma has a unique worldwide racial and geographic distribution. Our objective was to evaluate socioeconomic disparities in the burden of nasopharyngeal cancer (NPC) between endemic and nonendemic regions....
8.
Fribley A, Xi Y, Makris C, Alves-de-Souza C, York R, Tomas C, et al.
ACS Med Chem Lett
. 2019 Feb;
10(2):175-179.
PMID: 30783499
Spiroimines are a class of compounds produced by marine dinoflagellates with a wide range of toxicity and therapeutic potential. The smallest of the cyclic imines, portimine, is far less toxic...
9.
Ramsey T, Guo E, Svider P, Lin H, Syeda S, Raza S, et al.
Laryngoscope
. 2018 Mar;
128(9):2039-2053.
PMID: 29508408
Objectives/hypothesis: To characterize health burden and determine the associated level of equality of laryngeal carcinoma (LC) burden at a global level. Methods: One hundred eighty-four countries were organized by socioeconomic...
10.
Rayess H, Xi Y, Garshott D, Brownell A, Yoo G, Callaghan M, et al.
Oral Oncol
. 2018 Jan;
76:27-33.
PMID: 29290283
No abstract available.